Joshua Elson, M.D., MPH
Joshua Elson is originally from the midwest, being born and raised in Cincinnati, Ohio. He performed his undergraduate studies at the University of Michigan, where he stayed to complete a Master of Public Health (MPH) in epidemiology. After graduating with his MPH he worked as a clinical research coordinator at the University of California, San Francisco. He studied medicine at Ben-Gurion University of the Negev in Israel, earning his Doctor of Medicine (MD) degree. He then went on to complete a 1-year internal medicine internship at Maimonides Medical Center in Brooklyn, New York, and a 4-year residency in radiation oncology at the University of Cincinnati.
He has interest in population-based research studies and has published in the journal Cancer, among others. He is now the medical director of the radiation oncology department at the Aurora Cancer Care Center in Kenosha.
Selected Publications:
Elson JK, Kachnic LA, Kharofa JR. Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study. Cancer. 2018 Nov 15;124(22):4383-4392. doi: 10.1002/cncr.31721. Epub 2018 Oct 17. PMID: 30329160.
Elson JK, Beebe-Dimmer JL, Morgenstern H, Chilkuri M, Blanchard J, Lentsch AB. The Duffy Antigen/Receptor for Chemokines (DARC) and prostate-cancer risk among Jamaican men. J Immigr Minor Health. 2011 Feb;13(1):36-41. doi: 10.1007/s10903-010-9330-z. PMID: 20596779; PMCID: PMC3017736.
Scher ED, Elson JK, Kharofa JR. Prognostic implications of advancing nodal stage in anal cancer: evaluating AJCC 8 staging changes through an NCDB analysis. Int J Colorectal Dis. 2020 Nov;35(11):2099-2104. doi: 10.1007/s00384-020-03688-7. Epub 2020 Jul 21. PMID: 32691133.
Prasad RN, Elson JK, Kharofa J. The effect of dose escalation for large squamous cell carcinomas of the anal canal. Clin Transl Oncol. 2018 Oct;20(10):1314-1320. doi: 10.1007/s12094-018-1863-y. Epub 2018 Apr 5. PMID: 29623585.
